The "Single-use Bioreactors Market Size, Share & Trends Analysis Report by Product, by Type, by Type Of Cell, by Molecule Type, by Application, by End-use, by Usage Type, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
By 2030, the global single-use bioreactors market is expected to be USD 12,062.5 millions. From 2022 to 2030, the market will grow at a 17.6% CAGR. The market for single-use bioreactors will experience significant growth due to rising demand for biopharmaceuticals and increasing investments in single use technologies.
Industry's tendency to use single-use bioreactors is influenced by the product's value, time needed for product development and production, as well as the criticality of each phase. These single-use bioreactors are also in high demand by the medical industry. These reactors are used by pharmaceutical companies to produce medicines that do not compromise their quality. One of the main advantages of single-use bioreactors lies in their flexibility. Multi-drug facilities are becoming more popular. This means that multiple medications can be manufactured in one facility. It is also possible to do so quickly and cost effectively. It will drive market growth and increase demand for single-use bioreactors.
The market for single-use bioreactors will grow rapidly due to the prospects in emerging countries, demand for personalized medicine, and an expected rise in biosimilar production within the U.S. By 2020, for instance, approximately $110 billion in biologics are likely to lose patent protection. As a result, the demand for biosimilar will rise over the next years due to rising healthcare costs and regulatory certainty regarding biosimilar. This will further drive market growth.
The market's growth is likely to be slowed by the administration of single use bioreactors and concerns about extractable and leachable. The single-use market for bioreactors is expected to reap the benefits of emerging markets and license terminations. The market is driven primarily by SUB usage by startups and small businesses, technological advancements in SUB and the benefits these products offer.
In modern biopharmaceutical operations, SUBs are being used more often. Because of their exceptional ability to improve flexibility, reduce investment, and manage operational expenses, SUBs are becoming more popular. Single-use bioreactors can be used in a variety of applications, including in drug discovery, pharmaceutical, industrial, and life science research, for example, to produce vaccines, antibodies and cell culture. It will also increase market demand and boost growth.
Highlights of the Single-Use Bioreactors Market Report
The single-use bioreactor systems segment held the largest share of the market in 2021, according to product. Market growth is expected to be driven by the availability of disposable bioprocess bags of different sizes, which can be used for storage of buffers, reagents and sera as well as cell culture.
The market share for stirred tank bioreactors was higher by type in 2021. This is due to the growing adoption of stirred tanks SUBs from pilot scale production to large scale manufacturing.
The mammalian cell segment held the largest share of all segments based on their type in 2021. This segment is driven by increasing use of single-use bioreactors to culture mammalian cells in multiple research studies. Another key factor that will drive market growth is the rising popularity of single-use bioreactors.
Based on molecule type insights, vaccines accounted for a greater share of the market in 2021. Because they are less expensive, and also come in smaller quantities, this is possible. This allows manufacturers to quickly test different cell lines and growth conditions faster and at lower costs to improve vaccine manufacturing.
According to application insights, the research & development (R&D/process development) segment accounted for a greater share of 2021's market. The most common use of single-use bioreactors is in (GMP), process development and research. The market is also growing due to the increasing use of single-use bioreactors for process development.
According to usage insights, lab-scape production accounted for a greater share of the market in 2021. Before scaling up, it is important to include all types of bioreactor operation and waste creation in controlled laboratory-scale studies. The market is expected to grow due to the many advantages of lab-scalee bioreactors.
End-use insights revealed that the CMOs & CROs sector held a greater share of 2021. CMOs are constantly changing their processing lines and facilities, so the stabler product developers for bioprocessing equipment and facilities are more important. This is driving market growth
The following are the key topics covered:
Chapter 1 Scope and Methodology
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends, & Scope
Chapter 4: Competitive Landscape
Chapter 5 Single – Use Bioreactors Market Analysis
Chapter 6 Single – Use Bioreactors Market Type Business Analysis
Chapter 7 Single – Use Bioreactors Market Analysis: Type Of Cell Business Analysis
Chapter 8 Single – Use Bioreactors Market Analysis: Molecule Type
Chapter 9 Single – Use Bioreactors Market Analysis: Application Business Analysis
Chapter 10 Single – Use Bioreactors Market Analysis: Usage Type
Chapter 11 Single – Use Bioreactors Market : End - Use Business Analysis
Chapter 12 Single – Use Bioreactors Market Analysis Regional Business Analysis
Chapter 13 Company Profiles
Able Corporation & Biott Corporation
Bbi - Biotech GmbH
Celltainer Biotech Bv
G&G Technologies, Inc.
Sigma - Aldrich Co. LLC
Satake Chemical Equipment Mfg. Ltd.
Pbs Biotech, Inc.
Solida Biotech GmbH
Stobbe Pharma GmbH
Thermo Fisher Scientific, Inc.
Visit URL for more information on this report